ACG 2019: JAK inhibitor & DVT, budesonide for eosinophilic oesophagitis

The American College of Gastroenterology held its 2019 Annual Scientific Meeting in San Antonio, Texas. Here are some of the presentations that grabbed our attention: JAK inhibitor off the hook for DVT? A post-hoc analysis of trials of tofacitinib in patients with ulcerative colitis has provided some reassuring evidence that rates of DVT or PE ...

Already a member?

Login to keep reading.

© 2021 the limbic